InkVivo Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.33M

  • Investors
  • 10

InkVivo General Information

Description

Developer of drug delivery systems designed for the localized and temporal release of various active ingredients, including small molecules, biologics, and micronutrients. The company's targeted and sustained release technology allows for more effective treatments with reduced dosing frequency and minimized side effects, enabling pharmaceutical, nutraceutical, and veterinary industries to regulate the release of ingredients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Piazza Cioccaro 4
  • 6900 Lugano
  • Switzerland
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Decision/Risk Analysis
Corporate Office
  • Piazza Cioccaro 4
  • 6900 Lugano
  • Switzerland

InkVivo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InkVivo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Seed Round 04-Jun-2025 $1.33M Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Seed Round 01-May-2024 Completed Generating Revenue
5. Accelerator/Incubator 01-Nov-2022 Completed Startup
4. Grant 27-Sep-2022 Completed Generating Revenue
3. Accelerator/Incubator 02-Dec-2021 Completed Startup
2. Grant 13-Nov-2021 $27.3K Completed Startup
1. Spin-Off 01-Jan-2020 Completed Startup
To view InkVivo’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InkVivo Patents

InkVivo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026022379-A1 Gastroretentive formulations Pending 26-Jul-2024

InkVivo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InkVivo Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Claves Investments Corporation Minority
Creadd Ventures Venture Capital Minority
TiVenture Venture Capital Minority
SICTIC Accelerator/Incubator Minority
USI Startup Centre Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

InkVivo FAQs

  • When was InkVivo founded?

    InkVivo was founded in 2020.

  • Where is InkVivo headquartered?

    InkVivo is headquartered in Lugano, Switzerland.

  • What is the size of InkVivo?

    InkVivo has 10 total employees.

  • What industry is InkVivo in?

    InkVivo’s primary industry is Drug Delivery.

  • Is InkVivo a private or public company?

    InkVivo is a Private company.

  • What is InkVivo’s current revenue?

    The current revenue for InkVivo is .

  • How much funding has InkVivo raised over time?

    InkVivo has raised $1.41M.

  • Who are InkVivo’s investors?

    Claves Investments, Creadd Ventures, TiVenture, SICTIC, and USI Startup Centre are 5 of 10 investors who have invested in InkVivo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process